Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCellular and Molecular

Cyclosporine A Downregulates Selenoprotein P Expression via a Signal Transducer and Activator of Transcription 3–Forkhead Box Protein O1 Pathway in Hepatocytes In Vitro

Xingyu Yao, Hiroaki Takayama, Kyoko Kamoshita, Hein Ko Oo, Ryota Tanida, Kaisei Kato, Kiyo-Aki Ishii and Toshinari Takamura
Journal of Pharmacology and Experimental Therapeutics August 2022, 382 (2) 199-207; DOI: https://doi.org/10.1124/jpet.121.001175
Xingyu Yao
Department of Endocrinology and Metabolism, (X.Y., H.T., Ky.K., H.K.O., R.T., Ka.K., T.T.), Life Sciences Division, Engineering and Technology Department (H.T.), and Department of Integrative Medicine for Longevity (K.-A.I.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa City, Ishikawa Prefecture, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroaki Takayama
Department of Endocrinology and Metabolism, (X.Y., H.T., Ky.K., H.K.O., R.T., Ka.K., T.T.), Life Sciences Division, Engineering and Technology Department (H.T.), and Department of Integrative Medicine for Longevity (K.-A.I.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa City, Ishikawa Prefecture, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyoko Kamoshita
Department of Endocrinology and Metabolism, (X.Y., H.T., Ky.K., H.K.O., R.T., Ka.K., T.T.), Life Sciences Division, Engineering and Technology Department (H.T.), and Department of Integrative Medicine for Longevity (K.-A.I.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa City, Ishikawa Prefecture, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hein Ko Oo
Department of Endocrinology and Metabolism, (X.Y., H.T., Ky.K., H.K.O., R.T., Ka.K., T.T.), Life Sciences Division, Engineering and Technology Department (H.T.), and Department of Integrative Medicine for Longevity (K.-A.I.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa City, Ishikawa Prefecture, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryota Tanida
Department of Endocrinology and Metabolism, (X.Y., H.T., Ky.K., H.K.O., R.T., Ka.K., T.T.), Life Sciences Division, Engineering and Technology Department (H.T.), and Department of Integrative Medicine for Longevity (K.-A.I.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa City, Ishikawa Prefecture, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaisei Kato
Department of Endocrinology and Metabolism, (X.Y., H.T., Ky.K., H.K.O., R.T., Ka.K., T.T.), Life Sciences Division, Engineering and Technology Department (H.T.), and Department of Integrative Medicine for Longevity (K.-A.I.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa City, Ishikawa Prefecture, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiyo-Aki Ishii
Department of Endocrinology and Metabolism, (X.Y., H.T., Ky.K., H.K.O., R.T., Ka.K., T.T.), Life Sciences Division, Engineering and Technology Department (H.T.), and Department of Integrative Medicine for Longevity (K.-A.I.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa City, Ishikawa Prefecture, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshinari Takamura
Department of Endocrinology and Metabolism, (X.Y., H.T., Ky.K., H.K.O., R.T., Ka.K., T.T.), Life Sciences Division, Engineering and Technology Department (H.T.), and Department of Integrative Medicine for Longevity (K.-A.I.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa City, Ishikawa Prefecture, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Toshinari Takamura
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

Cyclosporine A (CsA) is an immunosuppressant applied worldwide for preventing graft rejection and autoimmune diseases. However, CsA elevates oxidative stress, which can lead to liver injuries. The present study aimed to clarify the mechanisms underlying the CsA-mediated oxidative stress. Among the redox proteins, CsA concentration-dependently downregulated Selenop-encoding selenoprotein P, a major circulating antioxidant protein reducing reactive oxygen species, in hepatocytes cell lines and primary hepatocytes. The luciferase assay identified the CsA-responsive element in the SELENOP promoter containing a putative binding site for forkhead box protein O (FoxO) 1. The CsA-mediated suppression on the SELENOP promoter was independent of the nuclear factor of activated T-cell, a classic target repressed by CsA. A chromatin immunoprecipitation assay showed that CsA suppressed the FoxO1 binding to the SELENOP promoter. Foxo1 knockdown significantly downregulated Selenop expression in H4IIEC3 cells. Furthermore, CsA downregulated FoxO1 by inactivating its upstream signal transducer and activator of transcription 3 (STAT3). Knockdown of Stat3 downregulated Foxo1 and Selenop expression in hepatocytes. These findings revealed a novel mechanism underlying CsA-induced oxidative stress by downregulating the STAT3-FoxO1-Selenop pathway in hepatocytes.

SIGNIFICANCE STATEMENT This study shows that Cyclosporine A (CsA) downregulates Selenop, an antioxidant protein, by suppressing the signal transducer and activator of transcription 3–forkhead box protein O1 pathway in hepatocytes, possibly one of the causations of CsA-induced oxidative stress in hepatocytes. The present study sheds light on the previously unrecognized CsA-redox axis.

Footnotes

    • Received February 24, 2022.
    • Accepted May 19, 2022.
  • This research was supported by the Japan Agency for Medical Research and Development [Grant JP19am0101086, support number 0059], [Grant JP19lm0203005j0003]; the Japan Society for the Promotion of Science KAKENHI [Grant JP18K19560]; and Takeda Science Foundation (to T.T.).

  • No author has an actual or perceived conflict of interest with the contents of this article.

  • ↵1 X.Y. and H.T. contributed equally to this work.

  • https://doi.org/10.1124/jpet.121.001175.

  • ↵Embedded ImageThis article has supplemental material available at jpet.aspetjournals.org.

  • Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 382 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 382, Issue 2
1 Aug 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cyclosporine A Downregulates Selenoprotein P Expression via a Signal Transducer and Activator of Transcription 3–Forkhead Box Protein O1 Pathway in Hepatocytes In Vitro
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCellular and Molecular

CsA Downregulates Selenop Expression via a STAT3-FoxO1 Axis

Xingyu Yao, Hiroaki Takayama, Kyoko Kamoshita, Hein Ko Oo, Ryota Tanida, Kaisei Kato, Kiyo-Aki Ishii and Toshinari Takamura
Journal of Pharmacology and Experimental Therapeutics August 1, 2022, 382 (2) 199-207; DOI: https://doi.org/10.1124/jpet.121.001175

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCellular and Molecular

CsA Downregulates Selenop Expression via a STAT3-FoxO1 Axis

Xingyu Yao, Hiroaki Takayama, Kyoko Kamoshita, Hein Ko Oo, Ryota Tanida, Kaisei Kato, Kiyo-Aki Ishii and Toshinari Takamura
Journal of Pharmacology and Experimental Therapeutics August 1, 2022, 382 (2) 199-207; DOI: https://doi.org/10.1124/jpet.121.001175
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • N-stearoylethanolamine inhibits platelet reactivity
  • Anisodamine Ameliorates Acute Lung Injury
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics